擅长各类贫血性疾病的诊断和治疗，对于再生障碍性贫血、自身免疫性溶血性贫血、阵发性睡眠性血红蛋白尿、先天性及疑难贫血、纯红细胞再生障碍性贫血、慢性病贫血等疾病具有丰富的诊疗经验，尤其在重型再生障碍性贫血的免疫抑制治疗方面有20多年的经验，主要负责PNH的临床试验。

专家组医师及门诊时间：

     特需专家门诊：张凤奎、郑以州、施均

     专  家  门  诊： 邵英起、张莉、张静、聂能、方力维、彭广新、葛美丽、黄金波、赵馨、叶蕾、李星鑫

1.  Rabbit antithymocyte globulin as first-line therapy for severe aplastic anemia. Exp Hematol. 2015 Apr;43(4):286-94

2. 重组人血小板生成素对重型再生障碍性贫血免疫抑制治疗近期疗效的影响.中华血液学杂志,2015,36(3):181-185

3. Next generation sequencing revealed a rare case of co-existence of hereditary spherocytosis and dubin-johnson syndrome in a chinese gril: A case report. World J Clin Cases.2019 Oct 26;7(20):3303-3309

4. Red blood cell lifespan is reduced in severe aplastic anemia and improves with response to immunosuppressive treatment. Am J Hematol.2021Nov1;96(11)

5. 遗传性嘧啶5'核苷酸酶缺乏症NT5C3A基因新发变异位点二例报告并文献复习。中华血液学杂志2021年8月第42卷第8期 Chin J Hematol，August 2021，Vol. 42，No. 8

6. Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase 3, Randomized, Open-label, Multi-center FESTnd Study. Clinical cancer research.Clin Cancer Res (2021) 27 (1): 70–77.